Brazil Nuclear Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

Brazil nuclear imaging market size in 2026 is estimated at USD 257.48 billion, growing from 2025 value of USD 241.27 billion with 2031 projections showing USD 356.33 billion, growing at 6.72% CAGR over 2026-2031. This report is Segmented by Product (Equipment: PET/CT Scanners, SPECT/CT Scanners, PET/MRI Scanners; Radioisotopes: SPECT Radioisotopes, PET Radioisotopes), Application (Cardiology, Neurology, Thyroid, Oncology, Other PET Applications), End User (Hospitals, Diagnostic Imaging Centres, Academic & Research Institutes). The Market Forecasts are Provided in Terms of Value (USD).

Brazil Nuclear Imaging Market Trends and Insights

Escalating Cancer & CVD Incidence

Cardiovascular diseases remain Brazil’s primary mortality cause, driving sustained uptake of technetium-99m myocardial perfusion imaging and accelerating deployment of cadmium-zinc-telluride cardiac-dedicated gamma cameras that cut scan times to 7 minutes. Rising prostate, breast, and thyroid cancer prevalence also fuels demand for PSMA-targeted and 18F-fluorodeoxyglucose PET/CT studies. PET/CT-guided biopsies are delivering higher diagnostic yields than CT-guided protocols, while Brazilian investigators present outcome data on neuroendocrine tumor therapies at international congresses, underscoring domestic clinical expertise.

Expansion of Private Health-Insurance Coverage

Private providers conduct 82% of nuclear procedures, reflecting insurer willingness to reimburse high-complexity exams. Sector revenue of BRL 1 trillion (USD 190.1 billion) in 2025, with private spending at 55%, supports fresh capital deployment into imaging suites. Fleury’s BRL 69.8 million acquisition of São Lucas Centro de Diagnósticos typifies regional roll-outs, and a BRL 250 million health-finance fund now advances up to 75% of procedure costs immediately after service delivery, easing facility cash-flow constraints.

High Acquisition & Upkeep Cost of Imaging Systems

A PET/CT procedure currently costs USD 1,612.23 under academic wage scales and USD 1,023.47 at full 10-scan daily throughput, limiting small-facility economics. Fleury’s pivot toward joint ventures over outright purchases echoes industrywide capital-cost sensitivity. Maintenance of detectors and generator systems demands scarce technical expertise outside major cities, magnifying ownership burdens for interior clinics.

Other drivers and restraints analyzed in the detailed report include:

• Federal Investments in Domestically Produced Mo-99
• Rapid Adoption of Digital & Hybrid PET/CT Platforms
• Workforce Shortage of Certified Nuclear-Medicine Specialists

Segment Analysis

Brazil nuclear imaging market size for equipment reached USD 154.7 billion in 2025, representing 64.12% of total value. Hybrid PET/CT and SPECT/CT platforms account for the bulk of purchases as hospitals retire aging Anger cameras. Full-ring CZT SPECT systems improve coronary artery visualization and trim scan times, supporting higher patient throughput. The Brazil nuclear imaging market size for radioisotopes is forecast to rise at a 6.91% CAGR, propelled by RMB-enabled molybdenum-99 output and cyclotron expansion in underserved states. SPECT isotopes such as technetium-99m still represent 80% of procedure volume, yet PET tracers like 18F and 68Ga gain momentum in oncology and cardiology.

Financial hurdles persist. Capital cost per digital PET/CT exceeds USD 2 million, and rural clinics rely on leasing or volume-based vendor arrangements. GE HealthCare’s MINItrace Magni lowers tracer logistics costs, positioning mid-tier hospitals to upgrade. RMB production is slated to reduce 99Mo import costs by 40% once fully operational, enhancing isotope affordability. Long-term demand for PET/MRI remains niche due to USD 7 million price tags and high service requirements, yet early adopters cite diagnostic differentiation in neuro-oncology and congenital heart disease imaging.

Complete Report Scope:

• By Product (Value)
  • Equipment
    • PET/CT Scanners
    • SPECT/CT Scanners
    • PET/MRI Scanners
  • Radioisotopes
    • SPECT Radioisotopes
      • Technetium-99m (Tc-99m)
      • Thallium-201 (Tl-201)
      • Gallium-67 (Ga-67)
      • Iodine-123 (I-123)
      • Other SPECT Isotopes
    • PET Radioisotopes
      • Fluorine-18 (F-18)
      • Rubidium-82 (Rb-82)
      • Other PET Isotopes
• By Application (Value)
  • Cardiology
  • Neurology
  • Thyroid
  • Oncology
  • Other PET Applications
• By End User (Value)
  • Hospitals
  • Diagnostic Imaging Centres
  • Academic & Research Institutes

List of Companies Covered in this Report:

• GE HealthCare Technologies Inc.
• Siemens Healthineers
• Koninklijke Philips
• Canon
• United Imaging Healthcare Co., Ltd.
• Ion Beam Applications SA (IBA)
• Curium Pharma SA
• Bracco Imaging S.p.A.
• Cardinal Health
• Eckert & Ziegler AG
• Cyclobrás Tecnologias e Serviços de Medicina Nuclear Ltda.
• Diagnósticos da América S.A. (DASA)
• Grupo Fleury S.A.
• RPH Rede Brasileira de Farmácias de Radiofármacos

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support